4//SEC Filing
RUBINSTEIN JULIE 4
Accession 0001209191-21-015501
CIK 0001478320other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 9:00 PM ET
Size
9.5 KB
Accession
0001209191-21-015501
Insider Transaction Report
Form 4
RUBINSTEIN JULIE
President and COO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-02-26−15,000→ 240,325 totalExercise: $6.55Exp: 2028-02-07→ Common Stock (15,000 underlying) - Sale
Common Stock
2021-02-26$56.23/sh−15,000$843,450→ 0 total - Exercise/Conversion
Common Stock
2021-02-26$6.55/sh+15,000$98,250→ 15,000 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2020.
- [F2]The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $56.01 to 56.66, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
- [F3]The options vested with respect to 1/4 of such shares on November 1, 2018, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
Documents
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780664
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 9:00 PM ET
- Size
- 9.5 KB